Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Shuttle Pharmaceuticals Holdings, Inc. ( (SHPH) ) is now available.
On September 15, 2025, Shuttle Pharmaceuticals Holdings, Inc. entered into a consulting agreement with IR Agency LLC to enhance its communication with the financial community. The agreement, valued at $1,450,000, involves marketing and advertising services, including creating company profiles and building a digital community, and is set to last for two months.
Spark’s Take on SHPH Stock
According to Spark, TipRanks’ AI Analyst, SHPH is a Underperform.
Shuttle Pharmaceuticals Holdings, Inc. faces significant financial challenges with no revenue and ongoing cash burn. Technical indicators show bearish trends, and valuation metrics highlight the company’s unprofitability. While recent corporate activities offer potential strategic benefits, they also add financial strain and governance complexities, leading to an overall low stock score.
To see Spark’s full report on SHPH stock, click here.
More about Shuttle Pharmaceuticals Holdings, Inc.
Average Trading Volume: 105,334
Technical Sentiment Signal: Sell
Current Market Cap: $4.38M
For an in-depth examination of SHPH stock, go to TipRanks’ Overview page.